Literature DB >> 28993896

RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease.

Xiaoyong Li1, Lei Shi1, Ming Xu1, Xun Zheng1, Yiwen Yu1, Jing Jin2.   

Abstract

Congenital heart disease (CHD) is the most frequent birth defect. RCAN1 (regulator of calcineurin 1) contributes to CHD in Down syndrome. However, whether RCAN1 is also associated with nonsyndromic CHD remains unclear. This study sequenced the exons and flanking region of RCAN1 in 128 sporadic CHD patients and 150 normal controls. We identified six novel heterozygous mutations in CHD patients. Functional assay showed that the g.482G>T could obviously raise the promoter activity of RCAN1.4 in vitro; However, we failed to detect the expression of RCAN1 in the right auricle, which made it confused to evaluate the pathogenicity of this mutation. In addition, we demonstrated that c.290T>C and g.1056+58C>A had no effect on the alternative splicing of RCAN1. The *196C>T, *790G>A, and *1278C>G did not influence the translation of RCAN1 post transcription. In conclusion, a novel mutation of g.482G>T in RCAN1 may be related to CHD by causing overexpression of RCAN1.4.

Entities:  

Keywords:  Congenital heart defect; DSCR1; Down syndrome; Mutation

Mesh:

Substances:

Year:  2017        PMID: 28993896     DOI: 10.1007/s00246-017-1746-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  25 in total

1.  Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.

Authors:  Rick B Vega; Beverly A Rothermel; Carla J Weinheimer; Atilla Kovacs; R H Naseem; Rhonda Bassel-Duby; R S Williams; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

2.  Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.

Authors:  Katherine R Martin; Alicia Corlett; Daphne Dubach; Tomris Mustafa; Harold A Coleman; Helena C Parkington; Tobias D Merson; James A Bourne; Sílvia Porta; Maria L Arbonés; David I Finkelstein; Melanie A Pritchard
Journal:  Hum Mol Genet       Date:  2012-04-17       Impact factor: 6.150

3.  The transcription factor NF-ATc is essential for cardiac valve formation.

Authors:  A M Ranger; M J Grusby; M R Hodge; E M Gravallese; F C de la Brousse; T Hoey; C Mickanin; H S Baldwin; L H Glimcher
Journal:  Nature       Date:  1998-03-12       Impact factor: 49.962

4.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

Review 5.  Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease.

Authors:  C D Harris; G Ermak; K J A Davies
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

6.  Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis.

Authors:  Yili Wu; Weihong Song
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 7.  Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.

Authors:  Mary Ella Pierpont; Craig T Basson; D Woodrow Benson; Bruce D Gelb; Therese M Giglia; Elizabeth Goldmuntz; Glenn McGee; Craig A Sable; Deepak Srivastava; Catherine L Webb
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690

Review 8.  Transcription factors and congenital heart defects.

Authors:  Krista L Clark; Katherine E Yutzey; D Woodrow Benson
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

9.  Upregulation of RCAN1 causes Down syndrome-like immune dysfunction.

Authors:  Katherine R Martin; Daniel Layton; Natalie Seach; Alicia Corlett; Maria Jose Barallobre; Maria L Arbonés; Richard L Boyd; Bernadette Scott; Melanie A Pritchard
Journal:  J Med Genet       Date:  2013-05-03       Impact factor: 6.318

10.  Down syndrome and congenital heart disease: why the regional difference as observed in the Libyan experience?

Authors:  Z Elmagrpy; A Rayani; A Shah; E Habas; E H Aburawi
Journal:  Cardiovasc J Afr       Date:  2011 Nov-Dec       Impact factor: 1.167

View more
  4 in total

1.  ISL1 loss-of-function mutation contributes to congenital heart defects.

Authors:  Lan Ma; Juan Wang; Li Li; Qi Qiao; Ruo-Min Di; Xiu-Mei Li; Ying-Jia Xu; Min Zhang; Ruo-Gu Li; Xing-Biao Qiu; Xun Li; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

2.  A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle.

Authors:  Cai-Xia Lu; Wei Wang; Qian Wang; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

3.  Overexpression of Kif1A in the Developing Drosophila Heart Causes Valvar and Contractility Defects: Implications for Human Congenital Heart Disease.

Authors:  Takeshi Akasaka; Karen Ocorr; Lizhu Lin; Georg Vogler; Rolf Bodmer; Paul Grossfeld
Journal:  J Cardiovasc Dev Dis       Date:  2020-06-02

Review 4.  RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target.

Authors:  Shuai Wang; Yuqing Wang; Kaixin Qiu; Jin Zhu; Yili Wu
Journal:  Mol Med       Date:  2020-12-02       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.